baber/WOPTO huggingface dataset:
Patent PT-888514-E (PT)
Inventor: KEUS ELBERT CHRISTOFFEL EDWARD
IPC: F16M7/00
Filed: 1997-03-20
Abstract: PCT No. PCT/NL97/00145 Sec. 371 Date Oct. 15, 1998 Sec. 102(e) Date Oct. 15, 1998 PCT Filed Mar. 20, 1997 PCT Pub. No. WO97/35144 PCT Pub. Date Sep. 25, 1997A setting foot (1) for positioning machines, for example, on a base, comprises two setting members (2, 8) which can be mutually vertically displaced with respect to one another by a screw thread. The upper setting member (8) comprises a spherical surface, along which a bearing plate (17) with a spherical surface can slide. A first flexible sealing ring (21) may be accommodated between the lower (2) and the upper setting member (8), and, in the event of rotation of the upper setting member (8), bridges the spacing between the two setting members (2, 8). As a result, contamination of the screw thread is prevented. A second sealing ring (27) may be positioned along the outer circumference of the bearing plate (17), so that the curved surfaces are protected from the lateral penetration of dirt or moisture. A height indication (23) may be accommodated along the outer circumference of the upper or lower setting member (2, 8), which height indication can be covered by the sealing element (21). A lower O-ring (25) may also be accommodated, in order to prevent the penetration of moisture or dirt along the underside of the setting foot (1).
Patent PT-944596-E (PT)
Inventor: DENNY WILLIAM ALEXANDER
IPC: C07D209/12
Filed: 1997-12-12
Abstract: The present invention relates to novel amino analogues of the general class of cyclopropylindoles and their seco precursors, and is particularly concerned with the use of these compounds as prodrugs for antibody-directed enzyme-prodrug therapy (ADEPT) and gene-directed enzyme-prodrug therapy (GDEPT) for cancer.
Patent PT-970022-E (PT)
Inventor: HEIKO HESSENKEMPER PROF DR
IPC: C03B9/38
Filed: 1997-11-06
Abstract: The present invention aims at meeting the need to increase the fusion viscosity index of hollow glassware to ensure a more efficient cooling of same, thereby reducing the manufacturing run. According to the invention, the inner area of the hollow glassware is crossed by a gas medium characterized by a great radiation absorption capacity of 2000 to 5000 nm. Use can be made for example of propane, methane, carbon monoxide, carbon dioxide or water steam. The gas medium can be fed to either an open or closed cycle. The inventive method finds its application when cooling the hollow glassware in fusion, including all kinds of hollow glassware, glass tubes of the most various shapes and picture tubes.
Patent PT-951263-E (PT)
Inventor: ANHAUSER DIETER
IPC: A61F13/02
Filed: 1997-11-21
Abstract: A film dressing, in particular for the human or animal body, consisting of a flexible, conformable polymer film which is detachably bonded on the side facing away from the skin to a supporting sheet and is provided on the side facing the skin with a pressure sensitive adhesive layer which is in turn provided with an at least two-part protecting layer which can be pulled off, is characterized in that the protecting layer has hinge-like connections at two opposite edges to the supporting sheet.
Patent PT-990044-E (PT)
Inventor: SODERLIND ULF HANS ESKIL
IPC: C12Q1/6858
Filed: 1998-06-16
Abstract: The present invention relates to a method for in vitro evolution of protein function. In particular, the method relates to the shuffling of nucleotide segments obtained from exonuclease digestion. The present inventors have shown that polynucleotide fragments derived from a parent polynucleotide sequence digested with an exonuclease can be combined to generate a polynucleotide sequence which encodes for a polypeptide having desired characteristics. This method may be usefully applied to the generation of new antibodies or parts thereof having modified characteristics as compared to the parent antibody.
Patent PT-1025085-E (PT)
Inventor: MARYANOFF CYNTHIA
IPC: C07D261/08
Filed: 1998-10-09
Abstract: This invention relates a to a series of heterocyclic substituted piperazines of Formula Ipharmaceutical compositions containing them and intermediates used in their manufacture. The compounds of the invention selectively inhibit binding to the alpha-1a adrenergic receptor, a receptor which has been implicated in benign prostatic hyperplasia. As such the compounds are potentially useful in the treatment of this disease.
Patent PT-1051220-E (PT)
Inventor: SCOTT ERIK R
IPC: A61N1/30
Filed: 1999-01-28
Abstract: The present invention relates generally to an electrotransport device for transdermally or transmucosally delivering a beneficial agent (e.g., a drug) to the body surface of a patient or for transdermally or transmucosally sampling a body analyte. Most particularly, the present invention relates to a configured and electrochemically reactive electrode assembly having improved start-up electrical performance and improved lag time to compliant agent delivery.
Patent PT-1125016-E (PT)
Inventor: LJOKKOI RISTO
IPC: D21F1/66
Filed: 1999-09-22
Abstract: The present invention relates to the thickening of pulp suspensions. A low consistency pulp suspension is fed to a pre-thickener ( 10 ) through an inlet conduit ( 18 ). A layer of thickened pulp, formed on a filter surface ( 22 ), is pushed along the filter surface by a cleaning member to the discharge end of the pre-thickener and is discharged through the outlet ( 20 ). The cleaning member comprises a rotating shaft ( 30 ), on which shaft at least one screw thread ( 32 ) is fixed so as to leave a free space between the shaft and the screw thread. Essentially non-thickened pulp is allowed to flow through the apparatus via this space.
Patent IE-830185-L (IE)
Title: Enzymatic process for the determination of beta-lactam¹antibiotics
IPC: C12N11/08
Filed: 1983-01-31
Abstract: An enzymatic process for the determination of beta-lactam antibiotics in a biological liquid, comprising the steps of: (1) incubating the liquid with soluble D-alanyl-D-alanine-carboxypeptidase produced by Actinomadura R 39, said enzyme being immobilized on a water-insoluble support, the beta-lactam antibiotic reacting with the immobilized enzyme to form an inactive and equimolecular enzyme-antibiotic complex; (2) separating the immobilized enzyme from the liquid and washing it; (3) incubating the immobilized enzyme with a substrate solution to hydrolyze it and form an amount of D-alanine corresponding to the residual enzymatic activity; (4) determining the amount of D-alanine formed; and (5) comparing the determination of step (4) with a standard to obtain the concentration of the antibiotic in the biological liquid; as well as a test set for carrying out this process and comprising the necessary reagents.
Patent IE-38815-L (IE)
Title: 2, 9-dioxatricyclo [4, 3, 1, 03,7,] decanes
IPC: A61K31/343
Filed: 1974-02-04
Abstract: 1436821 4 - Hydroxy - 2,9 - dioxatricyclo [4,3,1,0<SP>3,7</SP>]decanes KALI-CHEMIE PHARMA GmbH 18 Jan 1974 [8 Feb 1973] 02548/74 Heading C2C Novel compounds I in which R 1 is C 1-4 alkyl, R 2 is OCOR 4 or OCONHR 5 when R 3 is hydrogen and R 3 is OCONHR 5 when R 2 is hydrogen (R 4 is C 1-4 alkyl and R 5 is a C 1-6 alkyl, C 2-6 unsaturated aliphatic, C 3-6 cycloaliphatic or aromatic group) and the 10,11 bond may be hydrogenated are prepared by reducing a compound III in which the 10,11 bond may be hydrogenated preferably with a metal hydride to form a mixture of the corresponding 4α- and 4#- hydroxy compounds and reacting the 4α-OH compound with a carboxylic acid chloride R 4 COCl, a carboxylic anhydride (R 4 CO) 2 O, an isocyanate R 5 NCO, an ester or chloride of a carbamic acid R 5 NH-COR 6 (in which R 6 is chlorine or alkoxy) or with phosgene followed by an amine R 5 NH 2 to form compounds I (R 3 =H): compounds I (R 3 = OCONHR 5 ) are prepared from the corresponding 4#-hydroxy compound by the methods described above. Compounds I have sedative, hyprotic and narcotic properties and may be administered orally or parenterally.
[GB1436821A]
Patent IE-39546-L (IE)
Title: Quinazoline derivatives
IPC: C07D403/12
Filed: 1974-02-27
Abstract: 1417029 Quinazoline - derived amines PFIZER Ltd 5 March 1974 [7 March 1973] 11018/73 Heading C2C The invention comprises compounds of formula and their pharmaceutically acceptable acid addition salts, wherein n is 1-3; R<SP>1</SP> is halogen, OH, PhCH 2 O, NH 2 or C 1-6 alkyl or alkoxy, provided that (R<SP>1</SP>) n contains at least one alkoxy group; R<SP>2</SP> is H, halogen or C 1-6 alkyl (optionally HO- or C 1-6 -alkoxy-substituted); R<SP>3</SP> is H, C 1-6 alkyl, PhCH 2 or Ph (optionally substituted by halogen or C 1-6 alkyl or alkoxy); R<SP>4</SP> is a C- attached N-containing aromatic heterocyclic group; and "alk" is C 1-4 alkylene. In examples, these compounds are prepared by reacting the appropriate 4-chloroquinazoline with R<SP>3</SP>NH-alk-R<SP>4</SP>, or by converting functional groups, by known procedures, in similarly prepared intermediates, in particular those of the above formula where the 4-substituent is N- methyl - 2 - (2 - pyridyl)ethyl and (i) R<SP>2</SP>= AcOCH 2 , (R<SP>1</SP>) n =6,7-(MeO) 2 , (ii) R<SP>2</SP>=H, (R<SP>1</SP>) n = 7-MeO-6-NO 2 , and (iii) R<SP>3</SP>=H, (R<SP>1</SP>) n = 6-EtOCO 2 -7-MeO. Therapeutic compositions having cardiac stimulant activity comprise compounds of the above formula, and may be administered orally or parenterally.
[GB1417029A]
Patent IE-780427-L (IE)
Title: Extrusion head
IPC: B29C48/12
Filed: 1978-03-01
Abstract: The extrusion adapter includes a breaker plate (16) placed between the tip (17) of the extruder screws and the pressure-equalising chamber (18). The downstream side of this breaker plate, coming before the pressure-equalising chamber, has a plane face whereas the upstream side has a recess which has the shape of a cone whose apex (opening) angle is the same as that of the tip of the screws. This breaker plate is formed by two series of parallel-axis channels (20). This extrusion adapter is intended especially for equipping a line for manufacturing products in the form of sheet (strip) by the cooking-extrusion-expansion process, in particular for the manufacture of food products. <IMAGE>
[GB1600783A]
Patent IE-45040-L (IE)
Title: Indoleamine-n-methyltransferase inhibitor
IPC: A61K31/425
Filed: 1977-04-29
Abstract: A method of inhibiting indoleamine-N-methyl transferase comprises the administration to a host of a therapeutically effective amount of a 3-hydrocarbyl-2-imino-thiazolidine or thiazoline or a pharmaceutically acceptable salt thereof.
[US4029803A]
Patent IE-34396-L (IE)
Title: Stabilized liquid detergent
IPC: C12N9/96
Filed: 1970-07-20
Abstract: 1278024 Biological detergent composition PROCTER & GAMBLE CO 21 July 1970 [23 July 1969] 35262/70 Heading C5D An enzyme-detergent composition stabilized against loss of enzymatic activity comprises (a) 1-65% of an organic detergent, (b) 0À01- 3% of calcium ion in the form of a watersoluble calcium salt, (c) 0À01-5% of an alkali metal thiosulphate, and (d) 60-40,000 amylase units per gram. Detergents specified include: the ammonium sulphate of trioxyethylenated coconut fatty alcohol containing C 10-16 alkyl groups, the sodium sulphonate of glycerolcoconut fatty alcohol ether, 3-(N,N-dimethyl- N-coconut alkyl ammonio) - 2 - hydroxypropane - 1 - sulphonate, coconut alkyl dimethylamine oxide, an adduct of 20 moles of ethylene oxide and 1 mole of coconut fatty alcohol, 1- (coconut alkyl - dimethylammonio) - propane sulphonate, a mixture of tri-, tetra- and pentapropylene alkyl benzene sulphonates, coconut fatty alcohol ammonium sulphate and coconut fatty acid monoethanolamide. Calcium salts specified include calcium acetate, chloride, citrate, glycerol phosphate, gluconate, glucoheptanate, lactate, leoninate, lactobionate, malate, lactophosphate, succinate and maleate. Alkali metal thiosulphates specified include sodium thiosulphate and potassium thiosulphate. The amylase may be derived from Bacillus subtilis. The composition may also include a protease derived from Bacillus subtilis, a solubilizing agent, e.g. ethanol, a viscosity control agent, e.g. potassium toluene sulphonate and potassium xylene sulphonate, an opacifier, e.g. ethylene glycol distearate, brighteners, perfumes, water, potassium chloride, citric acid, sodium silicate, and potassium pyrophosphate.
[GB1278024A]
Patent FI-830919-L (FI)
Inventor: LAWRENSON JACK
IPC: B24D3/32
Filed: 1983-03-18
Abstract: A metallic layer is removed from a coated glass surface (3) by subjecting the coated glass to the abrasive action of a stripping wheel (7) comprising a particulate abrasive in a porous matrix of polyvinyl formal.
Patent FI-831812-L (FI)
Inventor: KAMATH HUNDI PANDURANGA
IPC: H01C7/02
Filed: 1983-05-20
Abstract: Elongate electrical heaters which comprise at least two elongate conductors (3,4) and at least one elongate resistive heating strip (1) which contacts the conductors (3,4) alternately as it progresses down the length of the heater, and which is preferably composed of a conductive polymer, particularly a PTC conductive polymer. The conductors (3,4) can be separated from each other by an insulating strip (6), with the heating strip (1) being wrapped around the conductors (3,4) and the insulating strip (6). Alternatively the conductors (3,4) can be wrapped around a core comprising the heating strip (1) and an insulating strip (6). The junctions between the conductors (3,4) and the heating strip (1) are preferably coated with a low resistivity conductive polymer composition (9)..
Patent FI-844230-L (FI)
Inventor: SZELKE MICHAEL
IPC: C07K7/02
Filed: 1984-10-29
Abstract: Peptide analogues with formula (I), in which X and W are terminal groups which may contain other aminoacyl groups, Y, where it occurs, is glycine, phenylalanine or another lipophilic amino acid residue; Z is glycine, N-methyl- alanine, valine, proline or a ring homologue of proline; A is a "hydroxy", "reduced" or preferably "keto" dipeptide analogue residue, the first residue of which is either arginine or has a terminal amidino group of arginine in the side chain and the other is glycine, alanine or a corresponding residue with possibly a hydroxyterminal hydrocarbon side chain; Arg or Pro and Arg, where they occur, may possibly be substituted; and B, where it occurs, is valine, proline or a group -NH-(CH2)n-CO- (n = 0-5) or with W denotes an amino alcohol; and in which the terminal groups may possibly be bound to a cyclic structure. <IMAGE>
Patent IE-43476-L (IE)
Title: Compositions for flameproofing plastics
IPC: C08K3/22
Filed: 1976-06-08
Abstract: Compositions based on red phosphorus and a phenolformaldehyde polycondensate. These compositions contain from 50 to 95% by weight of red phosphorus and from 5 to 50% by weight of a thermoplastic phenol-formaldehyde polycondensate of molecular weight between 120 and 1,500, wherein the molar ratio of formaldehyde to phenol is between 0.7 and 0.9. These compositions are intended for the flameproofing of plastics and do not evolve toxic products during use.
[US4242240A]
Patent IE-40287-L (IE)
Title: Producing continuous band of rubberised fabric
IPC: B29C70/20
Filed: 1974-07-03
Abstract: A method is disclosed for accurately and readily forming a continuous band of rubberized fabric having transversal reinforcing metal elements by butt-splicing wherein a first and second piece of rubberized fabric having transversal reinforcing metal elements are positioned such that the initial end of the second piece is a predetermined distance from the terminal end of the first piece on a common plane with the reinforcing metal cords running parallel to the ends of the pieces, butt-splicing the pieces, without overlapping, by mutually approaching the pieces, obtaining a uniform accumulation of the rubber of the rubberized fabric about the reinforcing cords as well as a local thickening of the latter at a zone symmetrically situated with respect to the contact surface of the ends and whose width is proportional to the pre-established distance wherein the pieces are bound by the operating parts of the splicing apparatus, releasing the pieces from the operating parts of the splicing apparatus and winding up the continuous band on a collecting drum. An apparatus for producing the continuous band is also disclosed where the operating parts have a base element and a movable ledger capable of locking the pieces of rubberized fabric on a common plane by a series of fingers.[US3962022A]
Patent IE-801650-L (IE)
Title: Digital telecommunications exchange
IPC: H04J3/00
Filed: 1980-08-07
Abstract: It is an emerging international telecommunications requirement that all 32 channels of the p.c.m. multiplex must be switchable. The switching of channel zero relates to the "spare bits" not defined for synchronization purposes and these bits may be used as a data-bearer for network administration or control purposes. Digital telecommunication switching network, therefore, must be capable of concentrating channel assemblies of these spare bits into one transmit multiplex which may be connected to a spare bit data processor remote from the switching network or co-located with it. The passing of channel zero into the switch block, however, is dangerous because if this data is passed across the switch block to another digital line termination unit DLT in a time slot other than channel zero, then that receiving DLT will be called upon to transmit data containing two valid sets of sync and non-sync patterns which could confuse the synchronization circuits associated with the digital transmission system connected to that DLT. Such an arrangement is prevented using equipment in the receive and transmit DLT's. In the receive DLT after the incoming synchronization channel has fulfilled its synchronization purpose it is deliberately modified such that when switched to a transmit multiplex it will not be erroneously recognized as a sync channel. The modification does not of course cause loss of information contained in the spare bits or alarm bit. At the transmit DLT a decision is made as to whether the international bit in the sync pattern and the international bit and spare bits in the non-sync pattern should be transmitted to line as data ones or the patterns received.
[US4365330A]
Patent IE-811679-L (IE)
Title: Oral hygiene composition
IPC: C08G75/23
Filed: 1981-07-24
Abstract: Compositions and methods for preventing the attachment of dental plaque to the surfaces of the teeth of mammals comprise certain sulforated poly(arylene ether sulfone) polymers and the pharmaceutically acceptable salts thereof in a pharmaceutically acceptable vehicle, and the periodic application thereof to teeth.
[EP0045194A2]
Patent IE-41447-L (IE)
Title: Separation of sump products
IPC: B01D3/34
Filed: 1975-08-08
Abstract: 1511315 Thin layer evaporator BAYER AG 7 Aug 1975 [9 Aug 1974] 33011/75 Heading BIB A thin-layer evaporator comprises a spray ring 6 for the introduction of solvent to dissolve sump product, and, above this, a further spray ring. 4 for the introduction of vapour, e.g. steam, to form a vapour lock to isolate the distillate vapour from the solvent.
[GB1511315A]
Patent IE-44350-L (IE)
Title: 6ß,7Ó-DISUBSTITUTED-STEROID-17-SPIRO LACTONES AND CONGENERS
IPC: C07J1/00
Filed: 1976-09-21
Abstract: The preparation and valuable biological properties - especially diuretic activity - of 6 beta ,17-dihydroxy-7 alpha -(lower alkoxy)carbonyl-3-oxo-17 alpha -pregn-4-ene-21-carboxylic acid gamma -lactones and the corresponding hydroxy acids and salts thereof are disclosed.
[US3972871A]
Patent IE-902188-L (IE)
Title: Cationic fibre conditioning compositions
IPC: A61K8/895
Filed: 1990-06-18
Abstract: A fibre conditioning composition of improved fibre conditioning action includes a cationic surface active fibre conditioning agent and a particular type of water dispersible compound, which contains in its formula a long chain hydrocarbyl group, preferably linear alkyl, of at least 25 carbon atoms, with the proportion of such cationic surface active fibre conditioning agent to long chain hydrocarbyl-containing compound being in the range of 1:20 to 20:1. Because of the coaction of the components of such compositions the deposition of at least one of them on a fibrous substrate is increased, leading to better fibre conditioning action. Among the described compositions are conditioning rinses and shampoos for human hair, wash cycle and rinse cycle fabric softeners for laundry, and softergents, which are useful for washing laundry and simultaneously softening it. Preferred water insoluble compounds which contain in their formulas long chain hydrocarbyl grouops of at least 25 carbon atoms include alkanes, carboxylic acids, carboxylic acid esters, amides, amines amine salts, quaternary ammonium salts, and alcohols, some of which are available from certain petrolatums, paraffins, and beeswax.
[EP0407040A2]
Patent IE-802216-L (IE)
Title: Knitted cloth
IPC: D06M15/643
Filed: 1980-10-24
Abstract: PCT No. PCT/DE80/00161 Sec. 371 Date Jun. 25, 1981 Sec. 102(e) Date Jun. 25, 1981 PCT Filed Oct. 24, 1980.The resistance to deformation for extensions ranging up to 70% of the breaking elongation of a polyurethane-coated circular weft-knit or circular warp-knit fabric, especially such a fabric made from textured continuous-filament yarn with interlock bonding, is reduced by a polysiloxane elastomer finish to a value as low as one-fifth of that of polyurethane-coated fabric which does not have a polysiloxane elastomer finish. Such fabric is especially suitable for sport clothing, as well as all-weather clothing and stylish clothing.
[US4350725A]
Patent IE-41755-L (IE)
Title: Electric cell
IPC: H01M4/06
Filed: 1975-10-16
Abstract: Electric cell having a positive electrode comprising an active material intimately intermixed with an electronic conductor, a negative electrode and an electrolyte whose solvent is a non-aqueous liquid. According to the invention, the said electronic conductor is selected so as to bring down the discharge voltage peak of the cell occurring at the beginning of the discharge to or close to the desired operative voltage discharge level required in use of the cell. Batteries according to the invention are advantageously used in watches. (From US4018970 A) [FR2288401A1]
Patent IE-882269-L (IE)
Title: Injectable composition of opioid analgesic
IPC: A61K9/127
Filed: 1988-07-22
Abstract: A liposomal drug delivery and release system for the controlled release of opioid analgesics comprises opioid analgesic encapsulated in phospholipid vesicles, which, when administered to a patient, are shown to improve the drug's therapeutic efficacy and so sustain analgesia over an extended period of time.
Patent IE-822580-L (IE)
Title: Socket seal for concrete pipe
IPC: F16J15/14
Filed: 1982-10-27
Abstract: A socket seal for a tubular member defining a socket having an open end delimited by a free edge, an inner wall extending from the free edge and a base remote from the open end, and into the open end of which socket a further member is to be inserted to form a sealed connection, the seal being composed of a sealing ring made of an elastomer material and including a holding portion embedded in the tubular member in the region of the outer edge of the socket, a band-shaped fastening portion joined to the holding portion, and a sealing portion joined to the fastening portion and having a configuration such that it has a greater thickness at a point spaced from the fastening portion than at the location where it is joined to the fastening portion. The sealing portion is movable by bending relative to the fastening portion toward the base of the socket from an installation state to an operating state, the ring being configured such that in the operating state one surface of the sealing portion bears against the inner wall of the socket, and in the installation state the sealing ring delimits the free edge of the socket and the one surface of the sealing portion is approximately flush with the inner wall of the socket.
[US4483544A]